Patents by Inventor Chris T. Bond

Chris T. Bond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Patent number: 7534869
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Grant
    Filed: April 27, 2005
    Date of Patent: May 19, 2009
    Assignee: Icagen, Inc.
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Patent number: 7026451
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositons for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: April 11, 2006
    Assignees: Icagen, Incorporated, Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small conductance, calcium-activated potassium channels (SK 3)
    Patent number: 6987169
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: January 17, 2006
    Assignees: Oregon Health Sciences University, Icagen, Inc.
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Intermediate conductance calcium-activated potassium channels (IK1)
    Patent number: 6894147
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux though a calcium-activated potassium channel.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: May 17, 2005
    Assignees: Oregon Health Sciences University, Icagen, Inc.
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small conductance, calcium-activated potassium channels (SKI)
    Patent number: 6828420
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: December 7, 2004
    Assignees: Oregon Health Sciences University, Icagen, Inc.
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Nucleic acid encoding small conductance calcium-activated potassium channel (SK1)
    Patent number: 6828122
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: December 7, 2004
    Assignees: Oregon Health Sciences University, Icagen, Inc.
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small DNA encoding conductance, calcium-activated potassium channels (SK3)
    Patent number: 6828123
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: December 7, 2004
    Assignees: Oregon Health Sciences University, Icagen, Inc.
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Patent number: 6797486
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Grant
    Filed: May 24, 1999
    Date of Patent: September 28, 2004
    Assignees: ICAgen, Incorporated, Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • DNA encoding small and intermediate conductance calcium-activated potassium channels
    Patent number: 6692937
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: February 17, 2004
    Assignees: ICAgen, Incorporated, Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Publication number: 20030105284
    Abstract: This invention relates to small and intermediate conductance, calciumactivated potassium channel proteins. More specifically the invention relates to compositions and methods ror making and detecting calciumactivated potassium channel proteins and the nucleic acids encoding calciumactivated potassium channel proteins.
    Type: Application
    Filed: April 3, 2002
    Publication date: June 5, 2003
    Applicant: Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Publication number: 20030082684
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Application
    Filed: April 3, 2002
    Publication date: May 1, 2003
    Applicant: Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Publication number: 20030082683
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Application
    Filed: April 2, 2002
    Publication date: May 1, 2003
    Applicant: Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Publication number: 20030044910
    Abstract: This invention relates to small and intermediate conductance, calcium-acaivated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositons for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Application
    Filed: April 3, 2002
    Publication date: March 6, 2003
    Applicant: Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Publication number: 20030040048
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated potassium channel proteins. The invention also provides methods and compositons for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Application
    Filed: April 3, 2002
    Publication date: February 27, 2003
    Applicant: Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher W. Silvia
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Publication number: 20020192757
    Abstract: This invention relates to small and intermediate conductance, calcium-activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium-activated potassium channel proteins and the nucleic acids encoding calcium-activated proteins. The invention also provides methods for assaying compounds which increase or decrease potassium ion flux through a calcium-activated potassium channel.
    Type: Application
    Filed: April 3, 2002
    Publication date: December 19, 2002
    Applicant: Oregon Health Sciences University
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • SMALL AND INTERMEDIATE CONDUCTANCE, CALCIUM-ACTIVATED POTASSIUM CHANNELS AND USES THEREOF
    Publication number: 20020165379
    Abstract: This invention relates to small and intermediate conductance, calciumactivated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calciumactivated potassium channel proteins and the nucleic acids encoding calciumactivated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calciumactivated potassium channel.
    Type: Application
    Filed: May 24, 1999
    Publication date: November 7, 2002
    Inventors: JOHN P. ADELMAN, JAMES MAYLIE, CHRIS T. BOND, CHRISTOPHER P. SILVIA
  • Small and intermediate conductance, calcium-activated potassium channels and uses thereof
    Publication number: 20020155531
    Abstract: This invention relates to small and intermediate conductance, calcium activated potassium channel proteins. More specifically, the invention relates to compositions and methods for making and detecting calcium activated potassium channel proteins and the nucleic acids encoding calcium activated potassium channel proteins. The invention also provides methods and compositions for assaying compounds which increase or decrease potassium ion flux through a calcium activated potassium channel.
    Type: Application
    Filed: August 3, 2001
    Publication date: October 24, 2002
    Inventors: John P. Adelman, James Maylie, Chris T. Bond, Christopher P. Silvia
  • DNA encoding ATP-sensitive potassium channel genes
    Patent number: 5744594
    Abstract: This invention relates to DNA and protein compositions useful in the diagnosis and treatment of diabetes, heart disease and skeletal muscle disease. More specifically, this invention relates to DNA and protein compositions for ATP-sensitive potassium channel proteins, and methods of using these compositions.
    Type: Grant
    Filed: February 7, 1995
    Date of Patent: April 28, 1998
    Assignee: Oregon Health Sciences University
    Inventors: John P. Adelman, Michael J. Ashford, Chris T. Bond
  • Vectors and host cells expressing prepromotilin and motilin-associated peptide (MAP)
    Patent number: 5006469
    Abstract: cDNA encoding a precursor peptide for motilin has been retrieved from porcine gut tissue. The precursor protein contains a motilin-associated peptide (MAP) sequence conjugated to the motilin peptide through a trypsin-like cleavage site. The MAP is useful in regulating alimentary physiology in vertebrates. The DNA provides a means to obtain the corresponding DNAs in other vertebrate species, including humans. It also makes available recombinant motilin, motilin precursor, and MAP of any desired species.
    Type: Grant
    Filed: February 9, 1988
    Date of Patent: April 9, 1991
    Assignee: Oregon Health Sciences University
    Inventors: John P. Adelman, Chris T. Bond, Gajanan Nilaver, Earl A. Zimmerman